Study on intermittent hypoxia in children sleep apnea hypopnea syndrome model and insulin-like growth factor-1 and insulin-like growth factor binding protein-3 levels in serum.
- Author:
Jin HOU
1
;
Jing YAN
;
Quan-qing KANG
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Disease Models, Animal; Female; Hypoxia; blood; Insulin-Like Growth Factor Binding Protein 3; blood; Insulin-Like Growth Factor I; metabolism; Rats; Sleep Apnea Syndromes; blood
- From: Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2012;47(3):218-222
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVEUsing rats fed in intermittent hypoxia environment to study the relationship between sleep apnea hypopnea syndrome (SAHS) of children and growth retardation.
METHODSThe hypoxic chamber was designed and manufactured, the control of intermittent hypoxia was achieved. Twenty-four rats were randomly divided into three groups: mild and severe hypoxia group, and control group. In control group, the animals were normally fed, without interruption. The animals in other two groups were kept in the cabin, simulated mild and severe intermittent hypoxia conditions 8-hour a day, a total of 35 days. According to the results of preliminary experiments, the concentration of intermittent hypoxia and frequency were determined. The animals with mild hypoxia events occurred nearly six times per hour, the average minimum oxygen saturation dropped to 0.853, the animals with severe hypoxia events occurred nearly 24 times per hour, the average minimum oxygen saturation dropped to 0.776. Body mass and length were measured before and after experiment. The serum insulin-like growth factor (IGF)-1 and insulin-like growth factor binding protein (IGFBP)-3 expression were tested from venous blood by enzyme-linked immunosorbent assay (ELISA).
RESULTSThe length and body mass of rats in three groups before and after experiment were not statistically different (P>0.05). Before the experiment the serum IGF-1 and IGFBP-3 levels were not significantly different (P>0.05). 35 d after the experiment, the serum IGF-1 (x±s, the same below) in the control group, mild hypoxia and severe hypoxia were (60.0±18.5) ng/ml, (40.6±9.9) ng/ml and (13.1±8.6) ng/ml, F=25.840, P<0.01; the serum IGFBP-3 were (1.93±0.23) µg/ml, (1.39±0.30) µg/ml and (0.90±0.21) µg/ml, F=33.929, P<0.01. The differences were statistically significant. The IGF-1 and IGFBP-3 levels decreased as the hypoxia increased (P<0.05).
CONCLUSIONIn simulated sleep apnea hypopnea syndrome, the intermittent hypoxia in young rats does not show physical growth retardation, but the serum IGF-1, IGFBP-3 levels decreased with the increase of hypoxia and decline of oxygen saturation.